Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > eyes on the prize

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon May 28, 2023 7:32pm

128 Views

Post# 35468112

RE:RE:RE:eyes on the prize

As we can see unnoteable bashes ANYONE that does not totally agree with his narrative. He posts many things that are not pertinent to oncy and takes things out of context when he needs to. Unnoteable reminds me of an Ole wise proverb.... when you're up to ur neck in alligators.... it's hard to remember ur initial objective was to drain the swamp. I see more folks on here taking a realistic viewpoint instead of a dreamers viewpoint.... that is a good thing.

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it